Connect with us

Technology

Evolve Announces Estimated Annual Distributions for Certain Evolve Funds

Published

on

TORONTO, Nov. 29, 2024 /CNW/ – Evolve Funds Group Inc. (“Evolve”) announces the estimated special year end cash income and non-cash notional reinvested income and capital gains distribution per unit (the “Distributions”) for certain Funds (the “Evolve Funds”) for the 2024 tax year.

These estimates are for the annual cash income and non-cash capital gains and income distributions. Non-cash capital gains and income distributions are typically reinvested in additional units of the respective Funds at the year-end, and do not include estimates of ongoing monthly or quarterly cash distribution amounts. The additional units will be immediately consolidated with the previously outstanding units such that the number of outstanding units following the distribution will equal the number of units outstanding prior to the distribution. The reinvestment and immediate consolidation of additional units will result in an increase in the adjusted cost base of units outstanding.

Evolve’s estimates of cash income and non-cash capital gain and income distributions are for information purposes only, to aid with year-end tax and investment planning. These estimates are based on both preliminary and forward-looking information. Actual distributions may differ significantly from the estimates and some of the Funds may pay distributions above or below these estimated ranges, and Funds not currently expected to pay could be required to do so. These estimates are not intended to be used as tax advice. Because each investor’s tax situation is unique, a qualified tax advisor should be consulted.

Evolve expects to announce the final annual cash and reinvested distribution amounts on or about December 31, 2024 for all Evolve Funds with record date of December 31, 2024. The actual taxable amounts of cash and reinvested distributions for 2024, including the tax characteristics of the distributions, will be reported to brokers (through CDS Clearing and Depository Services Inc. or “CDS”) in early 2025.

The estimates are as of October 31, 2024 and could change due to events that occur between the date of these estimates and the date of the Funds’ taxation year end of December 31, 2024 for the High Interest Savings Account Fund, US High Interest Savings Account Fund, Premium Cash Management Fund and US Premium Cash Management Fund and of December 15, 2024 for all other Evolve Funds, and due to a number of factors.  These events and factors may include the following: 

The full measurement period is not captured by these estimates.Portfolio trading and market movements over the next several weeks.Estimates are indicated on a per-share basis. Changes in the number of shares outstanding can have a significant impact on these estimates.These estimates do not reflect all required tax adjustments. Certain tax adjustments are based on market value at a point in time and, therefore, cannot be estimated. Actual distribution amounts will be affected by all required tax adjustments and may be substantially different from these estimates.The period for the Funds’ taxation year may not correspond with the Funds’ fiscal year. This misalignment can have an impact on the amounts distributed and their tax characteristics.

To estimate the dollar value of a distribution for a Fund, multiply the Fund’s total per-share distribution estimate by the number of shares owned.

Evolve Funds

Ticker

Estimated
Reinvested
Income
Distribution
Per Unit

Estimated
Reinvested
Capital Gains
Distribution
Per Unit

Estimated
Cash
Income
Distribution
Per Unit

Currency

Evolve Canadian Aggregate Bond Enhanced Yield Fund

AGG

$0.00000

$0.00000

$0.00000

CAD

Evolve Artificial Intelligence Fund

ARTI

$0.00000

$0.00000

$0.00000

CAD

Evolve Canadian Banks and Lifecos Enhanced Yield Index Fund

BANK

$0.00000

$0.00000

$0.00000

CAD

Evolve Global Materials & Mining Enhanced Yield Index ETF

BASE

$0.00000

$0.00000

$0.00000

CAD

Evolve Global Materials & Mining Enhanced Yield Index ETF

BASE.B

$0.00000

$0.00000

$0.00000

CAD

Evolve Enhanced Yield Bond Fund

BOND

$0.00000

$0.00000

$0.00000

CAD

Evolve Enhanced Yield Bond Fund

BOND.B

$0.00000

$0.00000

$0.00000

CAD

Evolve Enhanced Yield Bond Fund

BOND.U

$0.00000

$0.00000

$0.00000

USD

Evolve US Banks Enhanced Yield Fund

CALL

$0.00000

$0.00000

$0.00000

CAD

Evolve US Banks Enhanced Yield Fund

CALL.B

$0.00000

$0.00000

$0.00000

CAD

Evolve US Banks Enhanced Yield Fund

CALL.U

$0.00000

$0.00000

$0.00000

USD

Evolve Automobile Innovation Index Fund

CARS

$0.00000

$0.00000

$0.08115

CAD

Evolve Automobile Innovation Index Fund

CARS.B

$0.00000

$0.00000

$0.10611

CAD

Evolve Automobile Innovation Index Fund

CARS.U

$0.00000

$0.00000

$0.04753

USD

Evolve Cyber Security Index Fund

CYBR

$0.00000

$0.00000

$0.00000

CAD

Evolve Cyber Security Index Fund

CYBR.B

$0.00000

$0.00000

$0.00000

CAD

Evolve Cyber Security Index Fund

CYBR.U

$0.00000

$0.00000

$0.00000

USD

Evolve Cloud Computing Index Fund

DATA

$0.00000

$0.00000

$0.00000

CAD

Evolve Cloud Computing Index Fund

DATA.B

$0.00000

$0.00000

$0.00000

CAD

Evolve Active Canadian Preferred Share Fund

DIVS

$0.00000

$0.00000

$0.10005

CAD

Evolve Active Global Fixed Income Fund

EARN

$0.00000

$0.00000

$0.33135

CAD

Evolve Bitcoin ETF

EBIT

$0.00000

$0.00000

$0.00000

CAD

Evolve Bitcoin ETF

EBIT.U

$0.00000

$0.00000

$0.00000

USD

Evolve European Banks Enhanced Yield ETF

EBNK

$0.00000

$0.00000

$0.00000

CAD

Evolve European Banks Enhanced Yield ETF

EBNK.B

$0.00000

$0.00000

$0.00000

CAD

Evolve European Banks Enhanced Yield ETF

EBNK.U

$0.00000

$0.00000

$0.00000

USD

Evolve Innovation Index Fund

EDGE

$0.00000

$0.00000

$0.16109

CAD

Evolve Innovation Index Fund

EDGE.U

$0.00000

$0.00000

$0.08822

USD

Evolve S&P 500® Enhanced Yield Fund

ESPX

$0.00000

$0.00000

$0.00000

CAD

Evolve S&P 500® Enhanced Yield Fund

ESPX.B

$0.00000

$0.00000

$0.00000

CAD

Evolve S&P 500® Enhanced Yield Fund

ESPX.U

$0.00000

$0.00000

$0.00000

USD

Evolve Cryptocurrencies ETF

ETC

$0.00000

$0.00000

$0.00583

CAD

Evolve Cryptocurrencies ETF

ETC.U

$0.00000

$0.00000

$0.00886

USD

Evolve Ether ETF

ETHR

$0.00000

$0.00000

$0.00000

CAD

Evolve Ether ETF

ETHR.U

$0.00000

$0.00000

$0.00000

USD

Evolve S&P/TSX 60 Enhanced Yield Fund

ETSX

$0.00000

$0.00000

$0.00000

CAD

Evolve Active Core Fixed Income Fund

FIXD

$0.00000

$0.00000

$0.00000

CAD

Evolve E-Gaming Index ETF

HERO

$0.00000

$0.00000

$0.00000

CAD

High Interest Savings Account Fund

HISA

$0.01589

$0.00000

$0.01478

CAD

US High Interest Savings Account Fund

HISU.U

$0.11793

$0.00000

$0.03880

USD

Evolve Future Leadership Fund

LEAD

$0.00000

$0.00000

$0.00000

CAD

Evolve Future Leadership Fund

LEAD.B

$0.00000

$0.00000

$0.00000

CAD

Evolve Future Leadership Fund

LEAD.U

$0.00000

$0.00000

$0.00000

USD

Evolve Global Healthcare Enhanced Yield Fund

LIFE

$0.00000

$0.00000

$0.00000

CAD

Evolve Global Healthcare Enhanced Yield Fund

LIFE.B

$0.00000

$0.00000

$0.00000

CAD

Evolve Global Healthcare Enhanced Yield Fund

LIFE.U

$0.00000

$0.00000

$0.00000

USD

Premium Cash Management Fund

MCAD

$0.00000

$0.00000

$0.04199

CAD

US Premium Cash Management Fund

MUSD.U

$0.00000

$3.15032

$0.03844

USD

Evolve NASDAQ Technology Index Fund

QQQT

$0.00000

$1.19006

$0.00000

CAD

Evolve NASDAQ Technology Index Fund

QQQT.B

$0.00000

$0.61190

$0.00000

CAD

Evolve NASDAQ Technology Index Fund

QQQT.U

$0.00000

$0.00000

$0.00000

USD

Evolve NASDAQ Technology Enhanced Yield Index Fund

QQQY

$0.00000

$0.00000

$0.00000

CAD

Evolve FANGMA Index ETF

TECH

$0.00000

$0.46186

$0.00000

CAD

Evolve FANGMA Index ETF

TECH.B

$0.00000

$0.72065

$0.00000

CAD

Evolve FANGMA Index ETF

TECH.U

$0.00000

$0.00000

$0.00000

USD

Evolve Canadian Utilities Enhanced Yield Index Fund

UTES

$0.00000

$0.00000

$0.00000

CAD

Distributions for the Funds will vary from period to period.  For further information regarding the Distributions, please visit www.evolveetfs.com

Commissions, management fees and expenses all may be associated with exchange traded funds (ETFs). ETFs are not guaranteed, their values change frequently and past performance may not be repeated. There are risks involved with investing in ETFs. Please read the prospectus for a complete description of risks relevant to ETFs. Investors may incur customary brokerage commissions in buying or selling ETF units. Please read the prospectus before investing.

Certain statements contained in this news release constitute forward-looking information within the meaning of Canadian securities laws. Forward-looking information may relate to a future outlook and anticipated distributions, events or results and may include statements regarding future financial performance. In some cases, forward-looking information can be identified by terms such as “may”, “will”, “should”, “expect”, “anticipate”, “believe”, “intend” or other similar expressions concerning matters that are not historical facts. Actual results may vary from such forward-looking information. Evolve undertakes no obligation to update publicly or otherwise revise any forward-looking statement whether as a result of new information, future events or other such factors which affect this information, except as required by law.

About Evolve Funds Group Inc.

With over $7.5 billion in assets under management, Evolve is one of Canada’s fastest growing ETF providers since launching its first ETF in September 2017. Evolve specializes in bringing innovative ETFs to Canadian investors. Evolve’s suite of ETFs provide investors with access to: (i) index-based income strategies; (ii) long term investment themes; and (iii) some of the world’s leading investment managers. Established by a team of industry veterans with a proven track record of success, Evolve creates investment products that make a difference.  For more information, please visit www.evolveetfs.com

Join us on social media: Twitter | LinkedIn | Facebook | Youtube

The S&P 500® Index and the S&P/TSX 60 Index are each a product of S&P Dow Jones Indices LLC or its affiliates (“SPDJI”), and has been licensed for use by the Evolve Funds. S&P® and S&P 500® are trademarks of S&P Global, Inc. or its affiliates (“S&P”); Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC (“Dow Jones”). It is not possible to invest directly in an index. The Evolve Funds are not sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, any of their respective affiliates (collectively, “S&P Dow Jones Indices”). S&P Dow Jones Indices does not make any representation or warranty, express or implied, to the owners of the Evolve Funds or any member of the public regarding the advisability of investing in securities generally or in the Evolve Funds particularly or the ability of the S&P 500® Index and the S&P/TSX 60 Index to track general market performance.  Past performance of an index is not an indication or guarantee of future results. S&P Dow Jones Indices’ only relationship to the Evolve Funds with respect to the S&P 500® Index and the S&P/TSX 60 Index is the licensing of the Indexes and certain trademarks, service marks and/or trade names of S&P Dow Jones Indices and/or its licensors.  The S&P 500® Index and the S&P/TSX 60 Index are determined, composed and calculated by S&P Dow Jones Indices without regard to the Evolve Funds.  S&P Dow Jpones Indices have no obligation to take the needs of the Evolve Funds or the owners of the Evolve Funds into consideration in determining, composing or calculating the S&P 500® Index and the S&P/TSX 60 Index. S&P Dow Jones Indices has no obligation or liability in connection with the administration, marketing or trading of the Evolve Funds. There is no assurance that investment products based on the S&P 500® Index or the S&P/TSX 60 Index will accurately track index performance or provide positive investment returns.  S&P Dow Jones Indices LLC is not an “investment adviser, commodity trading advisory, commodity pool operator, broker dealer, fiduciary, promoter” (as defined in the Investment Company Act of 1940, as amended), “expert” as enumerated within 15 U.S.C. s. 77k(a) or tax advisor.  Inclusion of a security, commodity, crypto currency or other asset within an index is not a recommendation by S&P Dow Jones Indices to buy, sell, or hold such security, commodity, crypto currency or other asset, nor is it considered to be investment advice or commodity trading advice.  

S&P DOW JONES INDICES DOES NOT GUARANTEE THE ADEQUACY, ACCURACY, TIMELINESS AND/OR THE COMPLETENESS OF THE S&P 500® INDEX AND THE S&P/TSX 60 INDEX OR ANY DATA RELATED THERETO OR ANY COMMUNICATION, INCLUDING BUT NOT LIMITED TO, ORAL OR WRITTEN COMMUNICATION (INCLUDING ELECTRONIC COMMUNICATIONS) WITH RESPECT THERETO.  S&P DOW JONES INDICES SHALL NOT BE SUBJECT TO ANY DAMAGES OR LIABILITY FOR ANY ERRORS, OMISSIONS, OR DELAYS THEREIN.  S&P DOW JONES INDICES MAKES NO EXPRESS OR IMPLIED WARRANTIES, AND EXPRESSLY DISCLAIMS ALL WARRANTIES, OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE OR AS TO RESULTS TO BE OBTAINED BY THE EVOLVE FUNDS, THE OWNERS OF THE EVOLVE FUNDS, OR ANY OTHER PERSON OR ENTITY FROM THE USE OF THE S&P 500® INDEX AND THE S&P/TSX 60 INDEX OR WITH RESPECT TO ANY DATA RELATED THERETO.  WITHOUT LIMITING ANY OF THE FOREGOING, IN NO EVENT WHATSOEVER SHALL S&P DOW JONES INDICES BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES INCLUDING BUT NOT LIMITED TO, LOSS OF PROFITS, TRADING LOSSES, LOST TIME OR GOODWILL, EVEN IF THEY HAVE BEEN ADVISED OF THE POSSIBLITY OF SUCH DAMAGES, WHETHER IN CONTRACT, TORT, STRICT LIABILITY, OR OTHERWISE.  S&P DOW JONES INDICES HAS NOT REVIEWED, PREPARED AND/OR CERTIFIED ANY PORTION OF, NOR DOES S&P DOW JONES INDICES HAVE ANY CONTROL OVER, THE LICENSEE PRODUCT REGISTRATION STATEMENT, PROSPECTUS OR OTHER OFFERING MATERIALS. THERE ARE NO THIRD-PARTY BENEFICIARIES OF ANY AGREEMENTS OR ARRANGEMENTS BETWEEN S&P DOW JONES INDICES AND THE EVOLVE FUNDS OTHER THAN THE LICENSORS OF S&P DOW JONES INDICES.

Nasdaq®, Nasdaq-100®, Nasdaq-100 Index®, Nasdaq-100 Technology Sector Adjusted Market-Cap Weighted™ Index are trademarks of Nasdaq, Inc. (which with its affiliates is referred to as the “Corporations”) and are licensed for use by Evolve ETFs. The Product(s) have not been passed on by the Corporations as to their legality or suitability. The Product(s) are not issued, endorsed, sold, or promoted by the Corporations. THE CORPORATIONS MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO THE PRODUCT(S).

SOURCE Evolve ETFs

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

IRIS Software Group Announces Intent to Acquire Dext Software Ltd.

Published

on

By

Acquisition to create an integrated, end-to-end solution, advance partner integrations, and drive product innovation for accountants and businesses globally 

LONDON, Dec. 3, 2024 /PRNewswire/ — IRIS Software Group (IRIS), a leading global provider of accountancy, education management, HR and payroll solutions, today announced a definitive agreement to acquire Dext Software Ltd (Dext), a leading bookkeeping automation platform provider. The acquisition will unite two sector-leading cloud-based platforms – Dext’s Bookkeeping Automation Platform and IRIS Elements – to deliver a complementary and fully integrated, end-to-end solution for accountants, bookkeepers, and businesses. 

On one side of the accounting value chain, IRIS Elements supports accountants and businesses with practice management and compliance functionality, such as accounts production and tax returns. On the other, Dext simplifies bookkeeping and improves productivity by automating routine tasks with AI. Together, both companies will cover the entire end-to-end accountancy workflow, from data entry and processing to compliance, reporting and advisory services. 

Currently, many accountants and businesses face “app fatigue” juggling multiple, disconnected tools to get their daily work done. Through integration, IRIS and Dext’s cloud platforms will connect seamlessly with a secure single sign-on (SSO) and share data effortlessly back and forth across both platforms. This will, effectively, create a single, end-to-end view of the entire accountancy workflow. By expanding the global digital footprint in countries like the UK, Canada, France and Australia, the acquisition will also support accountants in staying ahead of rapidly evolving global regulatory and compliance requirements. 

Commenting on the agreement, Elona Mortimer-Zhika, CEO of IRIS Software Group said, “With today’s exciting news, we are bringing together our amazing customers, partners, and employees to drive the future of tech in the accountancy industry. We are doubling down on our promise to build and offer the most compliant cloud solutions that deliver our customers the highest levels of productivity and engagement, giving them back the critical time they need to advise their clients, grow their businesses, and do what they love. Accountancy has been the heartland of IRIS for 46 years; together with Dext we have a shared passion to be the biggest supporters and best champions of accountants, globally.”

The transaction will allow IRIS to accelerate Dext’s product roadmap, infuse additional capital and enhance its partner integration program, which already connects to over 35 bookkeeping software platforms and over 11,500 banks & financial institutions. Both IRIS and Dext share a general ledger (GL)-agnostic strategy, ensuring their platforms can integrate with a wide array of accounting software and every bookkeeping provider – connecting multiple workflow streams and providing customers with unparalleled freedom of choice. Accountants and bookkeepers will have the flexibility to use their preferred bookkeeping tools while enjoying the benefits of a smooth, cohesive user experience. 

Sabby Gill, CEO of Dext added, “Joining forces with IRIS marks an exciting new chapter for Dext. This partnership enables us to accelerate our product innovation, deepen our integration program, and deliver a complete, end-to-end solution to our customers. I look forward to working alongside the IRIS team to unlock new opportunities for our customers and offer our team members expanded opportunities for personal and professional growth.” 

Upon closing, Sabby Gill will form part of the IRIS Global Executive team. The transaction is subject to customary closing conditions and is expected to be finalised by the end of this calendar year.  

Media contact:   
IRIS Software Group  
news@irisglobal.com  

About IRIS Software Group 
Founded in 1978, IRIS Software Group is a global provider of mission critical, cloud-hosted software solutions and services to more than 100,000 customers across 135 countries. IRIS is a trusted partner to businesses, finance, HR and payroll teams, educational organisations, and accountancy firms of all sizes, providing innovative operational solutions that streamline complex processes, maintain compliance, and unlock growth. Through simplifying, automating and providing insights on everyday mission critical tasks for organisations of all shapes and sizes, IRIS ensures customers can look forward with certainty and confidence. IRIS is certified as a 2024 Great Place to Work® in the UK, Ireland, India, Romania, Canada and the USA. Follow IRIS on Facebook, TwitterInstagram and LinkedIn. More information on its award-winning software solutions can be found here.    

About Dext
Dext is the leading provider of bookkeeping automation, empowering businesses, accountants, and bookkeepers to thrive through innovative technology that simplifies accounting processes and drives smarter, more timely financial decisions. With financial data extraction accuracy of 99.5%, Dext has been trained on over 1 billion receipts and invoices.

Trusted by 12,000 accounting and bookkeeping firms and 700,00 businesses, Dext seamlessly integrates with most major accounting software and connects to over 11,500 banks, suppliers, and marketplaces worldwide. To date, the company has saved bookkeepers more than 35 million hours of manual data entry. As the global leader in bookkeeping automation, Dext maximizes efficiency and boosts productivity, liberating its customers to focus on what truly maters to them.

Dext was awarded the 2024 Xero Small Business App of the Year in both the UK and the US, plus Best Accounting and Pre-Accounting Specialists 2023 at the Worldwide Finance Awards 2023.

Logo – https://mma.prnewswire.com/media/2376347/5055983/Iris_Software_Logo.jpg

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/iris-software-group-announces-intent-to-acquire-dext-software-ltd-302320228.html

SOURCE IRIS Software Group

Continue Reading

Technology

AC Health makes critical HIV care more accessible to Filipinos with USAID support

Published

on

By

MANILA, Philippines, Dec. 3, 2024 /PRNewswire/ — Ayala Healthcare Holdings, Inc. (AC Health), in partnership with the U.S. Agency for International Development (USAID), is leading the private sector’s efforts to fight the HIV epidemic in the Philippines by improving access to stigma-free care and lifesaving services.

The partnership was sealed in time for World AIDS Day, whose theme “Collective Action: Sustain and Accelerate HIV Progress,” underscores the importance of collaboration to overcome this health challenge.

AC Health will leverage its unique ecosystem to develop, test, and scale approaches to improving and expanding HIV care and prevention services in the Philippines. AC Health will onboard qualified health service providers on the KonsultaMD platform and expand HIV awareness and screening services beyond health facilities. It will also import essential medicines and other lifesaving technologies through units IE Medica and MedEthix and make these commercially available through Generika Drugstore.

An important ally in the Philippines’ fight against HIV, USAID will support community engagement, provide technical assistance to Healthway Medical Network, and introduce private sector models for HIV service delivery. USAID will also train healthcare providers, share research, expand telehealth access through KonsultaMD, and coordinate with partners to provide free HIV self-testing kits.

“Our mission at AC Health is to make quality and affordable healthcare accessible to more Filipinos. Through our partnership with USAID, our dedicated teams at Healthway Medical Network, KonsultaMD, and Generika Drugstore have been equipped with specialized training to serve key populations affected by HIV. This collaboration brings us closer to bridging gaps in HIV prevention and testing, ensuring these critical services reach more communities nationwide,” said AC Health Chairman Fernando Zobel de Ayala.

The partnership is a key initiative to support the Philippines in addressing one of the fastest-growing HIV epidemics in Southeast Asia. AC Health’s participation also highlights its growing role in responding to public health challenges in the country.

AC Health, in partnership with Publicis Groupe Philippines and the People Management Association of the Philippines, is also leading the “Working with Cancer Pledge” in the country. This initiative is a global movement to raise awareness and support for people struggling with cancer in the workplace. Since its launch in 2023, hundreds of companies globally have been transformed into inclusive workplaces for employees dealing with cancer. 

AC Health, a wholly-owned subsidiary of Ayala Corporation, aims to provide every Filipino accessible, affordable, and quality healthcare. Its portfolio includes Generika Drugstore, the pioneer in generic retail pharmacies; St. Joseph Drug, a leading retail drugstore chain in North Luzon; IE Medica and MedEthix, a major pharmaceutical importer and distributor; Healthway Medical Network, a network of multi-specialty clinics, ambulatory centers, and full-service hospitals; and KonsultaMD, a healthcare aggregator app that offers online consultations, medicine delivery, and clinic and diagnostic booking. Through its three pillars—pharma, hospitals and clinics, and digital health—AC Health creates a seamless and integrated healthcare ecosystem for the Filipino patient.

About Ayala Corporation

For 190 years, Ayala Corporation has been building businesses that enable people to thrive.

Ayala, currently one of the largest conglomerates in the Philippines, has meaningful presence in real estate, banking, digital solutions, and renewable energy. It likewise has a growing presence in healthcare, mobility, and logistics as well as investments in industrial technologies, education, and other ventures. Ayala manages its corporate social responsibility initiatives through Ayala Foundation.

Visit our website at https://ayala.com and by follow us on LinkedIn to learn more about the company.  

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ac-health-makes-critical-hiv-care-more-accessible-to-filipinos-with-usaid-support-302320617.html

SOURCE Ayala Healthcare Holdings, Inc.

Continue Reading

Technology

CLAIRE’S CONTINUES MOMENTUM IN BEAUTY WITH THE INTRODUCTION OF C BY CLAIRE’S

Published

on

By

The exclusive, new collection of luxurious body care and fragrances is inspired by and tailored to Gen Zalpha’s everyday lifestyles

HOFFMAN ESTATES, Ill., Dec. 3, 2024 /PRNewswire/ — Global fashion brand Claire’s is continuing its evolution within the beauty category with the launch of C by Claire’s, an exclusive line of fragrances and body care products designed to help Gen Zalpha feel their most confident. Building on the success of Claire’s existing body care product collection, the new line gives consumers even more bespoke scents to love and furthers Claire’s impact in the category.

The new collection features luxurious foaming moisturisers, bath and body scrubs, fragrances, hair and body mists, and more, meeting consumers’ demands for beauty products that help them feel empowered in the same way that the brand’s signature fashion accessories have for over 50 years. C by Claire’s is crafted with high-quality ingredients in delightful, original scents like Cherry Bliss, Cloudberry Fizz, Watermelon Kiss, and Salted Caramel, with many catering to the growing gourmand scent trend. Each product is presented in vibrant packaging that reflects the bold, expressive spirit of Claire’s and its consumers.

A marquee of this collection, Claire’s is introducing an all-new signature fragrance, aptly titled “Be The Most” in a nod to the brand’s platform rooted in self-expression. The fragrance boasts a delicate blend of pistachio, vanilla musk, silky sandalwood, and Italian citrus, ideal for both everyday wear and special occasions.

“At Claire’s, we continually seek innovative ways to engage with our consumers and provide the products, categories, and experiences that excite them,” said Meghan Hurley, VP of Marketing at Claire’s. “We know beauty is a space that our Gen Zalpha consumers are passionate about, and we’re thrilled to give them another avenue to express themselves through this new collection.”

Supporting the collection is Claire’s CGI-centric Christmas campaign which comes to life across the brand’s retail, digital and social channels spotlighting Claire’s as the ultimate destination for the gift-giving season across jewellery, toys, tech and more. In time for the festive season, the line also includes gift sets and a “7 Days of Claire’s” advent calendar with daily surprises that are sure to delight.

C by Claire’s is the latest launch in Claire’s evolution into a full-fledged Gen Zalpha lifestyle brand. Priced from £12.00 to £25.00, C by Claire’s is now available in stores and online at Claires.com and will further expand with new products to love, offering even more reasons to shop at Claire’s. Follow along @Clairesstores to stay in the know on the latest collections, style tips, and more.

About Claire’s Holdings LLC
Claire’s Holdings LLC is a fully integrated, global fashion brand powerhouse committed to inspiring self-expression through the creation and delivery of exclusive, well-curated products and experiences. For over 50 years, Claire’s has been a destination for the curious, creative and influential and an industry-leader in ear piercing services, delivering a trendsetting assortment of fashion products and accessories that help young people worldwide style and define themselves. Through its global brands, Claire’s® and Icing®, the company delivers an immersive, omnichannel shopping experience with owned and concession stores throughout North America and Europe as well as franchise stores in the Middle East and South Africa. More information regarding Claire’s is available at corporate.claires.com.

MEDIA CONTACTS
Katie Settle, Katie.Settle@claires.com

Photo – https://mma.prnewswire.com/media/2556170/2024_CL_C_By_Claires_Beauty_Bagstuffer_001_R_sRGB__1.jpg

Logo – https://mma.prnewswire.com/media/1631509/Claires_Stores_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/claires-continues-momentum-in-beauty-with-the-introduction-of-c-by-claires-302304908.html

Continue Reading

Trending